Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
abrdn Global Equity Impact A JETAX
- NAV / 1-Day Return 13.91 / −0.36 %
- Total Assets 42.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.150%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.97%
- Turnover 31%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0
Morningstar’s Analysis JETAX
Will JETAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S | 5.76 | 2.7 Mil | — |
Tetra Tech Inc | 5.42 | 2.5 Mil | Industrials |
ASML Holding NV | 4.59 | 2.1 Mil | Technology |
UnitedHealth Group Inc | 4.43 | 2.1 Mil | Healthcare |
RELX PLC | 4.43 | 2.1 Mil | Industrials |
Merck & Co Inc | 4.38 | 2.0 Mil | Healthcare |
Prologis Inc | 3.30 | 1.5 Mil | Real Estate |
NextEra Energy Inc | 3.29 | 1.5 Mil | Utilities |
Westinghouse Air Brake Technologies Corp | 3.29 | 1.5 Mil | Industrials |
Equinix Inc | 3.15 | 1.5 Mil | Real Estate |